Stonepine Capital Management, Llc Portfolio Stock Holdings
Stonepine Capital Management, Llc disclosed 65 stock positions valued at approximately $112.8 million in its latest SEC 13F filing. The largest holdings include VERASTEM INC, TENAX THERAPEUTICS INC, and EVOLUS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 14, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 65
- Portfolio Value
- $112.8M
Holdings by Sector
Stonepine Capital Management, Llc Portfolio Holdings in Q1 2026
41 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| VERASTEM INC | VSTM | Healthcare | 15.52% | 3,302,300 | +570,221 | +20.87% | $17,502,190 |
| TENAX THERAPEUTICS INC | TENX | Healthcare | 13.83% | 975,200 | +963,316 | +8105.99% | $15,593,448 |
| EVOLUS INC | EOLS | Healthcare | 6.41% | 1,759,091 | +127,503 | +7.81% | $7,229,864 |
| ADMA BIOLOGICS INC | ADMA | Healthcare | 5.91% | 740,000 | - | - | $6,667,400 |
| ZEVRA THERAPEUTICS INC | ZVRA | Healthcare | 3.97% | 480,000 | -89,088 | -15.65% | $4,473,600 |
| CORBUS PHARMACEUTICALS HLDGS | CRBP | Healthcare | 3.19% | 383,462 | -6,454 | -1.66% | $3,600,708 |
| ABEONA THERAPEUTICS INC | ABEO | Healthcare | 2.97% | 746,587 | +37,082 | +5.23% | $3,344,710 |
| AN2 THERAPEUTICS INC | ANTX | Healthcare | 2.17% | 713,845 | +86,177 | +13.73% | $2,441,350 |
| XOMA ROYALTY CORPORATION | XOMA | Healthcare | 1.93% | 69,500 | -45,500 | -39.57% | $2,180,215 |
| AYTU BIOPHARMA INC | AYTU | Healthcare | 1.92% | 792,289 | -21,415 | -2.63% | $2,162,949 |
| CURIS INC | CRIS | Healthcare | 1.81% | 3,726,406 | +3,667,057 | +6178.80% | $2,039,462 |
| TELA BIO INC | TELA | Healthcare | 1.44% | 2,617,252 | +265,220 | +11.28% | $1,622,696 |
| INHIBIKASE THERAPEUTICS INC | IKT | Healthcare | 1.43% | 957,202 | -1,390,945 | -59.24% | $1,608,099 |
| HERON THERAPEUTICS INC | HRTX | Healthcare | 1.00% | 1,402,191 | +164,389 | +13.28% | $1,121,893 |
| PULMONX CORP | LUNG | Healthcare | 0.88% | 768,288 | +281,888 | +57.95% | $991,092 |
| SURROZEN INC | SRZN | Healthcare | 0.85% | 33,005 | -80,626 | -70.95% | $961,436 |
| PMV PHARMACEUTICALS INC | PMVP | Healthcare | 0.78% | 708,102 | -442,657 | -38.47% | $878,046 |
| MAXCYTE INC | MXCT | Healthcare | 0.63% | 1,004,673 | +535,655 | +114.21% | $705,783 |
| CODEXIS INC | CDXS | Healthcare | 0.60% | 417,994 | +161,888 | +63.21% | $681,330 |
| BOUNDLESS BIO INC | BOLD | Healthcare | 0.58% | 597,682 | -112,389 | -15.83% | $657,450 |
| ZENTALIS PHARMACEUTICALS INC | ZNTL | Healthcare | 0.56% | 269,100 | -194,600 | -41.97% | $629,694 |
| PHATHOM PHARMACEUTICALS INC | PHAT | Healthcare | 0.49% | 50,010 | +50,010 | +100.00% | $555,611 |
| CANDEL THERAPEUTICS INC | CADL | Healthcare | 0.45% | 102,500 | +102,500 | +100.00% | $502,250 |
| PRECISION OPTICS CORP INC MA | POCI | Healthcare | 0.39% | 100,000 | +100,000 | +100.00% | $439,000 |
| ESTABLISHMENT LABS HLDGS INC | ESTA | Other | 0.30% | 6,000 | +6,000 | +100.00% | $340,680 |
| OPUS GENETICS INC | OCUP | Other | 0.28% | 68,688 | +68,688 | +100.00% | $312,530 |
| ARVINAS INC | ARVN | Healthcare | 0.26% | 27,500 | +27,500 | +100.00% | $291,500 |
| PLIANT THERAPEUTICS INC | PLRX | Healthcare | 0.25% | 224,650 | -5,400 | -2.35% | $283,059 |
| JANUX THERAPEUTICS INC | JANX | Healthcare | 0.25% | 20,000 | - | - | $278,000 |
| OMNIAB INC | OABI | Healthcare | 0.23% | 164,045 | -536,955 | -76.60% | $257,551 |
| XERIS BIOPHARMA HOLDINGS INC | XERS | Healthcare | 0.21% | 40,030 | +40,030 | +100.00% | $232,174 |
| COMPUGEN LTD | CGEN | Other | 0.20% | 104,300 | -201,100 | -65.85% | $222,159 |
| NEUMORA THERAPEUTICS INC. | NMRA | Healthcare | 0.17% | 100,000 | +100,000 | +100.00% | $195,000 |
| SAB BIOTHERAPEUTICS INC | SABS | Healthcare | 0.17% | 50,000 | +50,000 | +100.00% | $191,500 |
| SI BONE INC | SIBN | Healthcare | 0.17% | 14,964 | +14,964 | +100.00% | $188,995 |
| EDESA BIOTECH INC | EDSA | Healthcare | 0.14% | 30,000 | -657,500 | -95.64% | $156,900 |
| CABALETTA BIO INC | CABA | Healthcare | 0.12% | 50,000 | -121,100 | -70.78% | $134,500 |
| ELEDON PHARMACEUTICALS INC | ELDN | Healthcare | 0.10% | 35,000 | -858,100 | -96.08% | $107,800 |
| OVID THERAPEUTICS INC | OVID | Healthcare | 0.08% | 40,000 | -62,367 | -60.92% | $88,800 |
| MANNKIND CORP | MNKD | Healthcare | 0.04% | 16,300 | -70,059 | -81.13% | $39,935 |
| BIOATLA INC | BCAB | Healthcare | 0.01% | 65,387 | +65,387 | +100.00% | $10,527 |
Stonepine Capital Management, Llc Options Holdings in Q1 2026
16 options positions in the latest reporting period.
Page 1 of 1
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q1 2026 | XBI | SPDR Series Trust SPDR S&P Bio | PUT | 400,000 | $51,092,000 |
| Q1 2026 | ADMA | ADMA Biologics Inc | CALL | 1,150,000 | $10,361,500 |
| Q1 2026 | TERN | Terns Pharmaceuticals, Inc. | CALL | 100,000 | $5,272,000 |
| Q1 2026 | ESTA | Establishment Labs | CALL | 50,000 | $2,839,000 |
| Q1 2026 | ARE | Alexandria Real Estate Equities | CALL | 50,000 | $2,321,000 |
| Q1 2026 | ACAD | ACADIA Pharmaceuticals Inc. | CALL | 100,000 | $2,226,000 |
| Q1 2026 | EOLS | Evolus, Inc. Common Stock | CALL | 420,000 | $1,726,200 |
| Q1 2026 | XERS | Xeris Biopharma Holdings, Inc. | CALL | 280,000 | $1,624,000 |
| Q1 2026 | SIBN | SI-BONE, Inc. | CALL | 100,000 | $1,263,000 |
| Q1 2026 | MNKD | MannKind Corporation | CALL | 500,000 | $1,225,000 |
| Q1 2026 | NMRA | Neumora Therapeutics, Inc. | CALL | 500,000 | $975,000 |
| Q1 2026 | CTMX | CytomX Therapeutics, Inc. | CALL | 200,000 | $940,000 |
| Q1 2026 | DCTH | Delcath Systems, Inc. | CALL | 100,000 | $928,000 |
| Q1 2026 | ARDX | Ardelyx, Inc. | CALL | 150,000 | $898,500 |
| Q1 2026 | HRTX | Heron Therapeutics, Inc. | CALL | 1,000,000 | $800,100 |
| Q1 2026 | ABEO | Abeona Therapeutics Inc. | CALL | 100,000 | $448,000 |
Notional value represents the total exposure of the options position.